3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Sezary Syndrome
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Hodgkin Disease
1
Carcinoma, Hepatocellular
1
Interventions
Peripheral Blood Stem Cell Transplantation
38
fludarabine phosphate
37
Cyclophosphamide
33
Mycophenolic Acid
28
Whole-Body Irradiation
24
Cyclosporine
24
Tacrolimus
22
Radiotherapy
19
Methotrexate
18
Busulfan
18
Antilymphocyte Serum
17
Filgrastim
14
Etoposide
14
Vorinostat
11
Bortezomib
11
Bexarotene
11
Methylprednisolone
10
Lenalidomide
10
pembrolizumab
9
Rituximab
9
Melphalan
9
Gemcitabine
9
Flow Cytometry
9
Brentuximab Vedotin
9
romidepsin
8
mogamulizumab
8
Methoxsalen
8
fludarabine
7
Magnetic Resonance Spectroscopy
7
Cord Blood Stem Cell Transplantation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mycosis Fungoides
×
resminostat
×
Clear all
NCT02953301
2024-08-30
RESMAIN
4SC AG
Phase 2
Completed
201 enrolled